Xin Ran

nifedipine · Shanghai Shyndec Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Xin Ran, covering 2015-02-05 to 2015-02-05. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy Study of Nifedipine Controlled-Release Tablets (Xin Ran) to Treat Mild to Moderate Essential Hypertension [Phase 4]

See pricing